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Summary
Bacteria regulate cell physiology in response to 
extra- and intracellular cues. Recent work showed 
that metabolic fluxes are reported by specific metab-
olites, whose concentrations correlate with flux 
through the respective metabolic pathway. An exam-
ple of a flux-signaling metabolite is fructose-1,6-bis-
phosphate (FBP). In turn, FBP was proposed to 
allosterically regulate master regulators of carbon 
metabolism, Cra in Escherichia coli and CggR in 
Bacillus subtilis. However, a number of questions on 
the FBP-mediated regulation of these transcription 
factors is still open. Here, using thermal shift assays 
and microscale thermophoresis we demonstrate 
that FBP does not bind Cra, even at millimolar physi-
ological concentration, and with electrophoretic 
mobility shift assays we also did not find FBP-
mediated impairment of Cra’s affinity for its operator 
site, while fructose-1-phosphate does. Furthermore, 
we show for the first time that FBP binds CggR within 
the millimolar physiological concentration range of 
the metabolite, and decreases DNA-binding activity 
of this transcription factor. Molecular docking exper-
iments only identified a single FBP binding site 
CggR. Our results provide the long thought after 
clarity with regards to regulation of Cra activity in 
E. coli and reveals that E. coli and B. subtilis use dis-
tinct cellular mechanism to transduce glycolytic flux 
signals into transcriptional regulation.
Introduction
Microorganisms display mechanisms that sense met-
abolic fluxes and translate this flux information into a 
cellular response (Fung et al., 2005; Kotte et al., 2010). 
Specifically, the concentrations of certain so-called 
flux-signaling metabolites correlate with the flux through 
the respective metabolic pathway (Litsios et al., 2017). 
A recognized flux-signaling metabolite is the glycolytic 
intermediate fructose-1,6-bisphosphate (FBP), whose 
concentration linearly correlates with the flux through 
glycolysis in Bacillus subtilis (Chubukov et al., 2013) 
and Escherichia coli (Kotte et al., 2010; Kochanowski 
et al., 2013), dynamically varying in a broad concen-
tration range: from 0.01 mM to around 15 mM (Bennett 
et al., 2009; Kleijn et al., 2009; Meyer et al., 2014; Link 
et al., 2015; Kochanowski et al., 2017). The flux-signal 
imprinted in the concentration of FBP is then used to 
exert flux-dependent actions, for instance, flux-depen-
dent allosteric regulation of transcription factors (TFs) 
or metabolic enzymes (Murcott et al., 1992; Cameron 
et al., 1994; Ormö et al., 1998; Yu and Pettigrew, 2003; 
Dombrauckas et al., 2005).
In particular, it has been reported that FBP regulates 
two pleiotropic TFs that have a central role in the gly-
colytic switch by controlling the expression of numer-
ous genes involved in carbon metabolism in bacteria. 
In E. coli, Cra (Catabolite repressor/activator) activates 
the transcription of genes encoding biosynthetic and 
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oxidative enzymes involved in the Krebs cycle, glyox-
ylate shunt and gluconeogenesis, and represses the 
transcription of genes involved in glycolysis (Ramseier 
et al., 1993; Bledig and Ramseier, 1996; Saier and 
Ramseier, 1996; Chavarría et al., 2011). In B. subtilis, 
CggR inhibits the transcription of the gapA operon, which 
encodes the five enzymes catalyzing the central part of 
glycolysis and cggR gene (Ludwig et al., 2001). Cells 
grown in glycolytic carbon sources induce gapA transcrip-
tion in response to a signal arising from central glycoly-
sis that alleviates CggR-mediated repression (Doan and 
Aymerich, 2003). According to our current knowledge, the 
interaction of FBP with the TFs impairs the affinity for their 
operator sequences (Ramseier et al., 1993; Doan and 
Aymerich, 2003), which would lead to the de-repression 
of target operons. However, so far a direct proof for the 
interactions between FBP at its physiological concentra-
tion range and these two TFs has not been revealed.
Recently, we found that in glucose-limited chemostat 
cultures Cra activity decreases with glycolytic flux while 
FBP levels increase (Kochanowski et al., 2013), which is 
consistent with the presumed inactivation of Cra by FBP. 
While the precise molecular mechanism is still obscure, 
Ramseier reported that 5 mM FBP partially displaced 
Cra-binding from the ppsA promoter in vitro (Ramseier et 
al., 1993), a result that the same authors claimed also for 
handful of other Cra target genes (Ramseier et al., 1995). 
In contrast, a recent comprehensive in silico, in vitro and 
in vivo analyses of the putative regulation by FBP of the 
homologue of Cra in Pseudomonas putida found only evi-
dence for fructose-1-phosphate (F1P) binding to Cra, but 
not FBP (Chavarría et al., 2011; Chavarría et al., 2014). 
However, because of the significant differences between 
upper glycolysis in P. putida and E. coli the regulation 
of Cra in these organisms might be also different. More 
recently, mutants of Cra were reported to display affin-
ities for FBP from nano to low micromolar range (Wei 
et al., 2016; Zhu et al., 2016). However, these authors 
could not find a significant effect of these mutations on 
either the regulation Cra’s DNA-binding activity in vitro 
or on transcriptional control of its targets in vivo (Wei et 
al., 2016; Zhu et al., 2016), which casts doubts about the 
specificity and the functional consequences of the alleged 
change in Cra’s affinity for FBP. Therefore, although it has 
been widely assumed that FBP regulates Cra in E. coli 
(Ramseier et al., 1993; Ramseier et al., 1995; Saier and 
Ramseier, 1996; Kotte et al., 2010; Kochanowski et al., 
2013; Chubukov et al., 2014; Lehning et al., 2017), a defi-
nite experimental and functionally relevant proof of the 
interaction between FBP and Cra is still missing.
Also for CggR, there are a number of open questions. 
Using fluorescence anisotropy and isothermal calorime-
try it has been consistently demonstrated that FBP binds 
CggR with high affinity (KD 2–7 µM) (Zorrilla, Chaix, et al., 
2007; Řezáčová et al., 2008). This interaction reduces 
the size of CggR oligomers and stabilizes dimers against 
denaturation but has no effect on DNA-binding activity 
(Zorrilla, Chaix, et al., 2007). In addition, different phos-
phorylated sugars (and even inorganic phosphate) can 
also bind FBP-binding site without triggering the induc-
tion response (Řezáčová et al., 2008). In fact, it is nec-
essary to add millimolar concentrations of FBP to affect 
CggR affinity for its operator by impairing the cooperativ-
ity in CggR-DNA interaction (Doan and Aymerich, 2003; 
Zorrilla, Chaix, et al., 2007), which led to hypothesize the 
occurrence of a second low affinity FBP-binding site that 
would be responsible for FBP-mediated allosteric regula-
tion of the TF (Doan and Aymerich, 2003; Zorrilla, Doan, 
et al., 2007; Chaix et al., 2010). However, this low affinity 
FBP-binding site could not be unveiled in CggR co-crys-
tallized in the presence of 90 mM FBP (Řezáčová et al., 
2008), and therefore, the mechanism by which FBP reg-
ulates CggR activity remains partially undefined. Thus, 
although millimolar concentrations of FBP modulate in 
vivo and in vitro CggR’s DNA binding activity, also here a 
direct proof of FBP-binding to CggR at this physiological 
concentrations of the metabolite is still missing.
Here, given the recently recognized importance of 
the flux-signaling metabolite FBP, we wanted to clarify 
if the glycolytic flux signal in the form of FBP is indeed 
transduced through the TFs Cra and CggR to generate 
a flux-dependent cellular response. Using thermal shift 
assays (TSA) and microscale thermophoresis (MST), 
we demonstrate that FBP does not bind Cra even at mil-
limolar concentrations of the metabolite, and show that 
also in E. coli F1P is the only effector of Cra. In contrast, 
we show that FBP does bind CggR within the physio-
logical concentration range of FBP (i.e., 0.5 to 10 mM). 
Electrophoretic mobility shift assays further confirmed an 
FBP concentration-dependent reduction in CggR affinity 
in the same concentration range, thus revealing that the 
interaction between the transcriptional repressor and FBP 
modulates its DNA-binding activity. Thus, in this work, we 
rule out a direct regulation of the transcription factor Cra by 
the flux-signaling metabolite FBP in E. coli, but show that 
glycolytic flux information is transduced through binding 
of FBP to CggR in B. subtilis. Untangling how metabolic 
fluxes are sensed and transduced is crucial to understand 
essential aspects of cell physiology (Papagiannakis et al., 
2017) and for metabolic engineering (Lehning et al., 2017).
Results
FBP neither binds nor regulates the E. coli Cra
It has been previously suggested that F1P traces con-
tained in commercial FBP might explain the observed 
FBP regulation of Cra (Ramseier et al., 1993; Chavarría 
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Fig. 1. The FBP samples tested contained less than 0.002% of F1P.
A. 1H-NMR spectrum of F1P (10 mM).
B. 1H-NMR spectrum of FBP (10 mM).
C. 1H-NMR spectrum of FBP (450 mM) with F1P (10 mM).
D. 1H-NMR spectrum of FBP (450 mM) with F1P (10 µM).
E. 1H-NMR spectrum of FBP (450 mM) only. The black arrows indicate the F1P peaks present in the selected region.
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et al., 2011). To avoid any confounding influence of F1P 
in our study, we used selective excitation NMR (Stott et 
al., 1995) to quantify F1P traces in our FBP solution. In 
specific, we first determined F1P and FBP proton spectra 
separately, and then selected a region with clear peaks 
in the F1P spectrum and no peaks from the FBP spec-
trum for our further analyses (Figure 1A-C). Using this 
region, we could only detect very weak F1P signals in a 
concentrated 450 mM FBP solution, which we estimated 
to correspond to a concentration of F1P of 9 µM (Figure 
1D-E). Thus, our FBP solution contained an F1P contam-
ination of less than 0.002%.
To investigate whether there is binding between Cra 
and FBP at physiological FBP levels and in cytoplas-
mic-like conditions, we used thermal shift assays (TSA), 
as this method tolerates complex buffers and high ligand 
concentrations (Grøftehauge et al., 2015). Ligand-binding 
may alter the thermal denaturation of a protein, which 
can be assessed in TSA by determining the change in 
protein’s melting temperature (Tm) in the presence of the 
ligand. Indeed, with the bona fide ligand of Cra, F1P, we 
found that increasing concentrations of F1P induced a 
gradual increase of Cra’s Tm up to 10°C (Figure 2A). In 
control experiments, we verified that the observed effects 
were not due to changes in ionic strength induced by the 
simultaneous titration of the F1P counter ions (2 K+ per 
F1P molecule) (Figure 2A and B, Supplementary Figure 
1). With FBP, we observed a 1.5°C decrease in the Tm of 
Cra only at the highest concentration point of the titration 
(30 mM) that cannot be attributed to the total increase in 
the Na+ counter ion concentration (Figure 2B). However, 
the amplitude of this change is very small (1.5°C com-
pared to 10°C with F1P), and we observed an increase in 
a similar magnitude in the presence of mannose-6-phos-
phate (Supplementary Figure 1), used here as a nega-
tive control, suggesting that these changes would mainly 
reflect unspecific binding events. Therefore, TSA provided 
no evidence that supports FBP binding to Cra.
Since we cannot rule out that FBP-binding induces only 
slight conformational changes not detectable by TSA, we 
further tested for binding between FBP and Cra using 
microscale thermophoresis (MST). Thermophoresis, the 
directed motion of a molecule in a temperature gradient, 
is highly sensitive to all kinds of binding-induced changes 
of molecular properties, such as size, charge or hydra-
tion shell, which can be monitored by different parame-
ters (fluorescence, thermophoresis, temperature jump) 
(Jerabek-Willemsen et al., 2011). Using this technique, we 
found that the fluorescence of Alexa-647-labeled Cra was 
quenched in the presence of F1P in a concentration-de-
pendent manner (Figure 2C). Because fluorescence stays 
constant when using denatured Cra in these binding 
Fig. 2. FBP does not bind E. coli Cra. Thermal shift assays (TSA) of Cra in presence of F1P (A) and FBP (B) (open circles). Titrations of K+ 
(KH2PO4) and Na+ (NaH2PO4) counter ions present F1P and FBP salt solutions respectively (closed circles). Points represent the mean and 
standard deviation of six (for F1P) and ten replicates (for FBP). Binding experiments of Cra and F1P (C), and Cra and FBP (D) as determined 
by microscale thermophoresis (MST). Plotted is the fluorescence of Cra labeled with Alexa-647 in presence of different concentrations of the 
metabolites F1P and FBP (open circles) or their respective counter ions (closed circles). MST measurements were performed in triplicate and 
the errors are given in standard deviation. The x-axes in all plots represent the concentrations of the metabolites or the respective KH2PO4 or 
NaH2PO4 control solutions.
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experiments (Supplementary Figure 2), the observed 
quenching must correspond to structural changes of 
native Cra resulting from F1P-binding. Also, the increase 
in K+ counter ions titrated along with F1P did not affect the 
fluorescence signals of labeled Cra (Figure 2C).
In contrast, we found no significant changes in the flu-
orescence of Cra in the presence of FBP (Figure 2D). 
Other parameters as quantified with MST showed only 
slight alterations at the highest concentrations of FBP 
tested (from 3 to 25 mM) (Supplementary Figure 3A-B). 
This observation is consistent with the results obtained 
with TSA and, together with the strong effect seen with 
F1P, support the notion that these changes only arise 
from non-specific interactions occurring at very high con-
centration of the FBP. Therefore, although it has been 
previously reported that addition of millimolar concentra-
tions of FBP reverses binding of Cra to its operator sites 
(Ramseier et al., 1993; Ramseier et al., 1995), neither our 
TSA nor MST support a direct interaction between FBP 
and Cra.
To resolve this discrepancy with the previous reports, 
we investigated the effect of FBP on Cra-binding to its 
DNA operator by electrophoretic mobility shift assays 
(EMSA). Here, we incubated a labeled DNA fragment 
containing Cra’s operator with Cra in the presence of 
different concentrations of FBP, F1P (positive control) or 
mannose-6-phosphate (M6P) (negative control), and 
resolved DNA-protein complexes and free DNA by electro-
phoresis in native conditions (Figure 3A, Supplementary 
Figure 4). Here, the addition of F1P gradually shifted the 
band in a concentration-dependent manner (Figure 3A – 
lanes 9 to 12). In contrast, FBP induced a faint increase 
in the intensity of lower band only at the highest concen-
trations of FBP tested (Figure 3A, Supplementary Figure 
4). We did not observe a similar decrease in the pres-
ence of the same concentrations of M6P (Supplementary 
Figure 4), which suggests that indeed F1P traces in our 
FBP solution (0.4 µM F1P in 20 mM FBP) could under-
lie this partial release of Cra from its operator. Together, 
these results demonstrate that FBP does not bind Cra nor 
allosterically regulates the affinity for its operator DNA 
sequence.
FBP binds and regulates CggR at millimolar 
concentrations
To determine whether FBP binds to CggR in the physio-
logical millimolar concentration range of the metabolite, 
we also first used TSA. In this case, FBP triggered a con-
centration-dependent increase in CggR’s Tm up to 6.9°C 
not related to the co-titration of Na+ counter ion (three 
molecules of Na+ per molecule of FBP), indicating occur-
rence of structural changes associated to FBP-binding 
(Figure 4A). Remarkably, these changes occurred over a 
concentration range (from 100 µM to 30 mM, Figure 4A) 
where the known high affinity binding site (KD ≈ 6 µM, 
(Zorrilla, Chaix, et al., 2007)) would long be saturated.
We next used MST to further confirm this binding of 
FBP with CggR at millimolar FBP concentrations. Here, 
we found that both CggR’s temperature jump (T-jump) 
and thermophoretic mobility were altered in the presence 
of FBP (Figure 4B, Supplementary Figure 5). Control 
experiments with sodium phosphate also showed a con-
centration-dependent decrease in the T-jump but con-
siderably smaller than that caused by FBP (Figure 4B, 
Supplementary Figure 5), which supports that FBP binds 
CggR within mM concentration range. Characterization of 
the affinity using a simple model based on the mass-ac-
tion law retrieved comparable values for the apparent 
KD from both the TSA and MST data (2.54 and 1.19 mM 
respectively; Table 1). Thus, these experiments revealed a 
direct interaction of FBP with CggR in the millimolar con-
centration range of the metabolite.
To determine the functional role of the observed inter-
action of FBP with CggR, we examined the effect millimo-
lar FBP concentrations on DNA-binding activity of CggR 
Fig. 3. F1P is responsible for regulating the interaction of Cra and 
the DNA operator, while FBP only shows a slight effect, most likely 
due to an unspecific effect.
A. EMSA analyzed with 5% TBE polyacrylamide gel 
electrophoresis. Lane 1: Cra DNA operator sequence. Lane 
2: Cra DNA operator sequence + BSA. Lanes 3 – 6: Cra DNA 
operator sequence + Cra + different concentrations of FBP. Lane 
7: Random DNA sequence. Lane 8: Random DNA sequence + 
Cra. Lanes 9 – 12: Cra DNA operator sequence + Cra + different 
concentrations of F1P.
B. and C. Quantification analysis of the DNA bands from the 
experiments with FBP and F1P. In these analysis, using ImageJ, 
each lane of the gel was selected and the area of each band 
estimated. The value of the upper bands, representing the DNA/
Cra complexes, were divided by the sum of the upper (bound DNA) 
and both lower bands (free DNA).
A
B C
Method KD ± IQR (mM) S.E.
Thermal shift assay 2.54 ± 0.17 0.02
MST 
– thermophoresis
1.24 ± 0.36 0.04
MST – temperature 
jump
1.19 ± 0.47 0.03
Table 1. Estimation of apparent binding affinity (KD) of CggR and 
FBP. IQR, interquartile range on measurement errors as 
determined by bootstrapping. S.E, standard error of the fit.
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using EMSA. In particular, a DNA fragment labeled with 
Alexa-647 containing the operator sequence from the 
gapA operon (Doan and Aymerich, 2003) was incubated 
with CggR in the presence of physiological concentra-
tions of FBP (5–20 mM). Here, we observed that FBP 
progressively reversed CggR’s shifted band in a concen-
tration-dependent manner down to 60% at 20 mM FBP 
(Figure 5A-B). In contrast, the band corresponding to the 
DNA-CggR complex remained unchanged in the pres-
ence of the same concentrations of the phosphorylated 
sugar M6P (Figure 5A). As the Na+ counter ion in the FBP 
salt solution is co-titrated along with FBP, causing its con-
centration to rise up to 70 mM (10 mM from the buffer + 
60 mM from 20 mM FBP concentration point), we next 
checked whether this increase could partially shield ionic 
interactions between CggR and its operator site and thus 
de-stabilize the DNA-protein complex irrespective of FBP. 
Here, when we titrated only the Na+, we did not observe 
changes in the shifted band (Supplementary Figure 6). 
Further, FBP-induced band shift reversion was also evi-
dent when we corrected for the salt content to precisely 
have the same concentration of Na+ (i.e., 100 mM) in 
every point in the FBP titrations (Supplementary Figure 6), 
which indicates that the differences in Na+ concentration 
did not play any role in the dissociation of CggR-DNA 
complex. Thus, collectively, these results show that FBP 
binds CggR at millimolar concentration, and that this inter-
action allosterically regulates DNA-binding activity of this 
transcription factor at physiological FBP concentrations.
Previous work has described that, in vitro, micromolar 
concentrations of FBP prevent high order oligomerization 
of CggR (Zorrilla, Chaix, et al., 2007), while millimolar con-
centrations are necessary to impair binding to the opera-
tor sequence (Doan and Aymerich, 2003; Zorrilla, Doan, 
et al., 2007). To explain these FBP concentration-depen-
dent effects of FBP in vitro, it has been proposed that two 
sugar binding sites exist in CggR, from which only one 
has been identified thus far (Zorrilla, Doan, et al., 2007; 
Zorrilla, Chaix, et al., 2007; Doan et al., 2008; Řezáčová et 
al., 2008). Towards identifying the potential second FBP 
binding site, we performed a molecular docking study. In 
the published structure (3BXF) (Řezáčová et al., 2008), 
CggR is a homodimer, in which FBP binds in subunit A, 
while dihydroxyacetonephosphate binds in subunit B at 
the same site (Supplementary Figure 7A). We started by 
removal of the two ligands from the structure and then per-
formed 800 docking runs with FBP as the ligand. Here, we 
found that FBP binding occurred 720 times in the already 
known binding site of subunit A and 80 times in the corre-
sponding site in subunit B (Supplementary Figure 7B). We 
found that the predicted FBP binding positions in subunit 
A all had steric overlap with the experimentally observed 
position of the FBP in the X-ray structure. The docking 
never predicted that binding would occur outside the 
already known binding site. As an extra control, given that 
FBP is strongly negatively charged, we also inspected 
an electrostatic surface map of CggR to search for sites 
with a positive charge. The only sites in the dimer that 
were conspicuously positively charged were the known 
Fig. 4. FBP binds CggR within millimolar concentration range of the metabolite.
A. The melting point (Tm) of CggR was determined in presence of FBP (open circles) or NaCl solutions (closed circles) used as control for the 
presence of the three sodium counter ions in FBP salts. Points represent the mean of six (FBP) and three (NaCl) experiments, and the error 
bars the standard deviation.
B. Microscale thermophoresis (MST) analysis of temperature jump of CggR in presence of different concentrations of FBP (open circles) 
and of NaH2PO4 solutions, as control (closed circles). Points represent the mean of four (FBP) and three (NaH2PO4) experiments, and the 
errors the standard deviation. The x-axis in both graphs describes the concentrations of FBP and the concentrations of the NaH2PO4 control 
solutions.
A B
Method KD ± IQR (mM) S.E.
Thermal shift assay 2.54 ± 0.17 0.02
MST 
– thermophoresis
1.24 ± 0.36 0.04
MST – temperature 
jump
1.19 ± 0.47 0.03
Table 1. Estimation of apparent binding affinity (KD) of CggR and 
FBP. IQR, interquartile range on measurement errors as 
determined by bootstrapping. S.E, standard error of the fit.
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binding sites. These results do not support the occurrence 
of a second binding site, and suggest that the binding site 
identified in the structure and docking studies is the only 
FBP-binding site in CggR.
Discussion
Here, using a set of biochemical techniques we inves-
tigated the binding of the flux-signaling metabolite FBP 
(Kochanowski et al., 2013) to the global transcription fac-
tors Cra of E. coli and CggR of B. subtilis. While to the 
best of our knowledge the only published evidence for 
the FBP-Cra interaction is a band shift assay where 5 
mM FBP induced a modest release of Cra from a 210 bp 
DNA fragment of ppsA promoter (Ramseier et al., 1993), 
it is widely considered that FBP binds and allosterically 
regulates this transcription factor (Ramseier et al., 1993; 
Ramseier et al., 1995; Saier and Ramseier, 1996; Kotte 
et al., 2010; Kochanowski et al., 2013; Chubukov et al., 
2014; Lehning et al., 2017). However, here, we could not 
find any evidence that demonstrates binding of FBP to E. 
coli ’s Cra, while with the two different techniques used 
(TSA and MST) we confirmed F1P-binding to Cra, and 
FBP-binding to B. subtilis transcription factor CggR. In 
addition, band shift experiments indicated a consistent 
effect on DNA-binding activity of Cra by F1P and of CggR 
by FBP, while FBP failed to impair DNA-Cra complex for-
mation. Thus, our analyses demonstrate that FBP nei-
ther binds nor regulates Cra DNA-binding activity in vitro 
and thus, is not a direct allosteric regulator of this tran-
scription factor in E. coli.
Ramseier et al. suggested that it cannot be ruled out 
that F1P traces in FBP solutions might be responsible for 
the weak effect they observed when using millimolar con-
centrations of FBP (Ramseier et al., 1993; Ramseier et al., 
1995). In agreement with this possibility, Chavarría et 
al. found only F1P associated with Cra after soaking the 
protein crystal in a 1 mM FBP solution (Chavarría et al., 
2011). However, no one has ever measured these traces, 
and thus this hypothesis could not be verified. Here, we 
quantified F1P traces in our FBP solution and found two 
molecules of F1P per 100,000 molecules of FBP. As the 
efficient concentration of F1P needed to dissociate DNA-
Cra complex is in the micromolar range (Fig. 3, (Ramseier 
et al., 1993)), F1P traces present in our FBP solution 
are largely insufficient to regulate Cra. Consistently, we 
observed an extremely small impairment of Cra’s DNA-
binding activity only at the highest concentrations of 
FBP (20–30 mM). As this impairment did not happen in 
presence of the same concentrations of another phos-
phorylated sugar (mannose-6-phosphate), this suggests 
that the minimal F1P traces (e.g., 0.6 µM F1P in 30 mM 
FBP) are responsible for this effect. Therefore, although 
F1P impurities in FBP solution used by Ramseier are 
not known, our results suggest that the changes of Cra’s 
affinity for its operator observed by these authors must 
indeed had been due to the presence of higher amounts 
of contaminating F1P.
Other contaminants, also present in binding assays, 
could also have influenced previous experiments (Wei 
et al., 2016; Zhu et al., 2016). For instance, counter ions 
present in phosphorylated metabolite salt solutions intro-
duced along with the ligand might affect electrostatic 
interactions involved in ligand–protein or protein–DNA 
contacts. In addition, ligands with ionizable groups at high 
concentration might exceed the buffering capacity, and 
Fig. 5. FBP interaction with CggR at millimolar concentration impairs CggR’s DNA-binding activity.
A. EMSA of CggR-DNA operator binding in the presence of FBP or M6P. Lane 1: Random DNA sequence. Lane 2: Random DNA sequence 
+ CggR. Lane 3: CggR DNA operator sequence. Lane 4: CggR DNA operator sequence + BSA. Lane 5 – 9: CggR DNA operator sequence + 
CggR + different concentrations of FBP. Lanes 10 – 13: CggR DNA operator sequence + CggR + different concentrations of M6P.
B. Quantification analysis of the DNA bands from the experiments with FBP (open circles) and M6P (closed circles). Bound/Total DNA 
corresponds to the intensity of the upper band (DNA-CggR complexes) divided by the sum of the intensities of the upper (bound DNA) and 
lower bands (free DNA). Points represent the mean of three replicates of FBP experiments and two replicates for M6P experiments. Error 
bars correspond to the standard deviation.
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consequently change the pH of the buffer. pH adjustment 
of ligand stock solution in turn will change final ions con-
centration (for instance, Na+ when using NaOH). Here, we 
adjusted the pH, recalculated the resulting ion concen-
tration in our metabolite solutions, and performed control 
experiments, in which we exclusively assessed the effect 
of the different salt concentrations on binding. Therefore, 
it is possible that observed effects in ITC experiments (cf. 
Wei et al., 2016; Zhu et al., 2016), or on Cra DNA-binding 
activity (cf. (Ramseier et al., 1993; Ramseier et al., 1995)) 
could also have resulted from effects of contaminant mol-
ecules (e.g., F1P, Na+, H+), titrated along with FBP.
In our prior work, we had found that in vivo the activity 
of Cra inversely correlates with intracellular FBP concen-
tration and glycolytic flux, independently on the carbon 
source or cultivation condition used (Kochanowski et al., 
2013), and we had proposed that FBP is a signal for gly-
colytic flux that would regulate Cra activity in a flux-de-
pendent manner. But if FBP is now not the regulator of 
Cra, why did we still observe glycolytic flux-dependent 
Cra activity (Kochanowski et al., 2013)? F1P is believed 
to be solely generated upon fructose uptake through the 
FruBA phosphotransferase system (Kornberg, 2001). 
Thus, how could the observed glycolytic-flux dependence 
Cra regulation take place in vivo? A recent systems-level 
analysis found that cyclic AMP, FBP and F1P alone 
explained most of the specific transcriptional regulation 
in E. coli through their interaction with the two major tran-
scription factors Crp and Cra (Kochanowski et al., 2017). 
Strikingly, among 47 central metabolites F1P displayed 
the highest intracellular concentration variance across 23 
different growth conditions and a highly significant direct 
correlation with FBP (Kochanowski et al., 2017), indicat-
ing that F1P is produced in E. coli also in conditions other 
than growth in fructose as the only carbon source. In this 
regard, a recent work described that the enzyme FruK 
can work reversibly and convert FBP into F1P (Singh et 
al., 2017). Interestingly enough, the same work reports 
that FruK interacts with Cra in vivo, and that conversion 
FBP into F1P regulates Cra/FruK affinity for Cra’s DNA 
operators in vitro (Singh et al., 2017). Thus, these results 
raise an interesting scenario where, similarly to cAMP or 
fructose-2,6-bisphosphate (in mammals), F1P would act 
as a second messenger (that is, not involved directly in 
central metabolism) to relay metabolic fluxes into a physi-
ological response, via regulation of Cra.
Next to Cra, in this work, we also performed a biochem-
ical characterization of the interaction between FBP and 
CggR. Previous studies have shown that in vitro FBP acts 
as a structural cofactor at micromolar FBP concentration 
and as a inducer at millimolar (Zorrilla, Doan, et al., 2007; 
Zorrilla, Chaix, et al., 2007). In order to explain this poten-
tial dual effect of the interaction of FBP with CggR, it has 
been argued that CggR possesses two distinct sugar-bind-
ing sites with different affinities (Zorrilla, Chaix, et al., 
2007). In this work, we demonstrate that FBP binds 
CggR at millimolar concentration and also releases the 
transcription factor from its DNA operator at this concen-
tration, but we could not find a second FBP-binding site 
different to the one experimentally identified and earlier 
characterized as the ‘high affinity site’ (Řezáčová et al., 
2008). Moreover, we found no positively charged surface 
areas other than the known FBP-binding site that might 
accommodate a phosphorylated metabolite. Consistently, 
Řezáčová et al. found a unique binding site in CggR 
crystals even when co-crystallizing the native protein in 
the presence of 90 mM FBP (Řezáčová et al., 2008). In 
this site, FBP establishes ionic interactions with Arg175 
(Řezáčová et al., 2008). CggR point mutant seems to 
have lost the cooperative binding to the operator DNA, is 
not sensitive by FBP regulation, and behaves as inactive 
repressor in vivo (i.e., constitutive expression of reporter 
gene under both glycolytic and gluconeogenic growth 
conditions) (Doan et al., 2008), indicating that FBP inter-
action at the known binding site underlies its activity as 
inducer. Thus, there is no experimental evidence that sup-
ports the existence of a second FBP-binding site in CggR 
and we conclude that the earlier reported ‘high affinity’ 
site is the only FBP-binding site in CggR, to which we find 
FBP to bind in the millimolar range.
Although previous work has demonstrated that FBP 
can bind CggR in vitro at concentrations much lower than 
the physiological one, the role of this interaction in vivo is 
not clear. In this regard, monophosphorylated metabolites 
(eg, dihydroxyacetone phosphate, glucose-6-phosphate 
and fructose-6-phosphate) can bind CggR with high affin-
ity to the same site as FBP, also without altering CggR’s 
DNA-binding activity (Doan et al., 2008; Řezáčová et al., 
2008). This poor selectivity, the fact that the physiologi-
cal concentration of these metabolites is much higher the 
affinity determined by ITC (Zorrilla, Chaix, et al., 2007; 
Řezáčová et al., 2008), and the lack of a functional conse-
quence in CggR DNA-binding activity (Doan et al., 2008) 
suggest that interactions at micromolar concentrations of 
the metabolites could only play an ancillary role in vivo.
In bacteria, intracellular concentration of most relevant 
metabolites typically ranges from hundreds of micromolar 
to millimolar (Bennett et al., 2009; Meyer et al., 2014). 
However, widely used benchmark methods for charac-
terizing molecular interactions (e.g., isothermal titration 
calorimetry) are very sensitive to buffer mismatch (i.e., 
presence of additional ions or contaminant traces in the 
ligand solution) and are more suitable to quantitatively 
determine affinities from sub-nanomolar to the micromo-
lar range, and thus are not optimal to assess allosteric 
interactions in the physiological concentrations ranges 
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of metabolites of primary metabolism. Here, using two 
biophysical techniques (MST and TSA) that are more 
appropriate to deal with complex buffers and high ligand 
concentrations (and an adequate set of controls) we clar-
ified conflicting results and unanswered questions rele-
vant for the regulation of two global bacterial transcription 
factors of carbon metabolism. In summary, this work 
contributes to understand fundamental questions about 
the regulation of Cra and CggR, clarifying long standing 
questions about binding partners and binding affinities.
Experimental procedures
Chemicals
D-Fructose-1,6-bisphosphate trisodium salt (FBP) 99% 
pure (MF03222) and D-mannose-6-phosphate diso-
dium salt hydrate (M6P) 95% pure (MM05046) were 
purchased from Carbosynth (UK); D-Fructose 1-phos-
phate dipotassium salt (F1P) 99% pure from Santa Cruz 
(Dallas, TX) (sc-500907A); and salmon sperm DNA from 
Sigma-Aldrich (D1626-1G).
The composition of all the buffers used are described 
in the Table 2.
Selective excitation NMR
Solutions of FBP and F1P were prepared in D2O and the 
spectra of FBP (10 mM) and F1P (10 mM) determined 
separately. The region selected for selective excitation 
displaying signals for F1P but not for FBP was centered at 
3.51 ppm with a width of 60.1 Hz. The detection limit of this 
method was estimated with samples prepared by mixing 
a high concentration of FBP (450 mM) with low concen-
tration of F1P (10 µM), and F1P traces were assessed in 
a 450 mM FBP solution. During the selective excitation, 
13C decoupling was used to suppress the 13C satellites of 
FBP. A relaxation time of 2 sec and an acquisition time 
of 1 sec were used. NMR spectra were zero filled once, 
and multiplied by an exponential line broadening function 
of 0.5 Hz prior to Fourier transformation. The number of 
scans used for the samples containing 450 mM FBP, and 
450 mM of FBP in combination with 10 µM of F1P, was 
1,024. For the samples containing 10 mM FBP and the 
sample with 10 mM F1P, 8 scans were used. The spectra 
were manually processed in MestReNova.
Protein expression and purification
Cra from E. coli was cloned in vector pBAD with a 
C-terminal His10-tag, and expressed in the E. coli 
strain MC1061, using an earlier described methodol-
ogy (Geertsma and Poolman, 2007). The primers used 
are described in the Supplementary Table 1. The syn-
thetic gene CggR was purchased from Life Technologies 
(Carlsbad, CA), and cloned in pET100/D-TOPO (Thermo 
Fisher Scientific; Waltham, MA), with an N-terminal His6-
tag. All constructs were verified by Sanger sequencing. 
For protein production, a single colony was used to inoc-
ulate 50 mL LB containing 100 µg mL-1 ampicillin, and the 
culture grown at 37°C overnight. This culture was diluted 
to an optical density (OD600) of 0.05 in a final volume of 1 
liter. Protein expression was induced at OD600 0.5 by addi-
tion of L-arabinose (0.01% v/v) (for Cra) or 10 µM IPTG 
(for CggR), and the cells subsequently grown at 30°C and 
180 rpm for four more hours. Cells were harvested by 
centrifugation at 6,600xg at 4°C for 20 min, washed once 
in modified cytosolic buffer (Table 2), and the pellet was 
frozen in liquid nitrogen and stored at -80°C.
For protein purification, cell pellets were resuspended in 
chilled lysis buffer (Table 2) and lysed by high-pressure dis-
ruption (Constant Cell Disruption System, Ltd, UK) in one 
passage at 25 Kpsi at 4°C. Lysate was cleared by centrifu-
gation at 30,000xg (Beckman JA-17 rotor), and incubated in 
batch with 0.5 mL of nickel-sepharose resin (pre-equilibrated 
with buffer A (Table 2)) at 4°C for 1 h. Subsequently, the sus-
pension was poured onto a 10 mL disposable column (Bio-
Rad), and the settled resin washed with 20 column volumes 
of buffer B containing imidazole (50 mM), followed by 20 
column volumes of buffer B containing L-histidine (50 mM). 
Table 2. Composition of buffer used in this study.
Buffer Composition pH
Buffer A Tris-HCl (50 mM) pH 7.2. 7
Buffer B Tris-HCl (50 mM) pH 7.2, NaCl (150 mM). 7
Lysis buffer Tris-HCl (50 mM) pH 7.2, NaCl (150 mM), EDTA (1 mM), PMSF (1 mM), MgCl2 (15 mM) and DNAse (10 μg mL-1).
7
Cytosolic buffer KH2PO4 (6 mM), K2HPO4 (14 mM); KCl (140 mM), glucose (5.5% w/v), MgCl2 (5 mM), NaCl (10 mM). 




KH2PO4 (6 mM), K2HPO4 (14 mM), KCl (140 mM), NaCl (250 mM). The pH was adjusted with a 1M 
KOH solution.
7
EMSA binding buffer NaH2PO4 (10mM), NaCl (100mM), EDTA (1mM), DTT (1mM), glycerol (5%). The pH was adjusted 
with 1M KOH .
7.8
for CggR, and F1P or FBP, for Cra, prepared in modified 
cytosolic buffer. The final concentrations of labeled Cra 
and CggR in the assay were 100 and 50 nM respectively. 
For MST measurements, samples were loaded in “pre-
mium coated capillaries” and analyzed in a MST Monolith 
NT.115 (both from NanoTemper Technologies; Munich, 
Germany) at 25°C, using 60% LED power and 40% 
IR-laser power. In control experiments with denatured Cra, 
before sample preparation the protein was denatured with 
7 M of urea and 1 mM DTT, and boiled for 10 minutes. 
In control experiments to assess the influence of counter 
ions in metabolite salt solutions the labeled proteins were 
added to a series of dilutions of KH2PO4 or NaH2PO4 
solutions prepared in cytosolic buffer (corresponding to 
K+ present in F1P and Na+ present in FBP and M6P solu-
tions respectively). The concentration range of each salt 
solution tested in these experiments was adjusted to the 
number of counter ions molecules co-titrated with the cor-
responding metabolite in binding experiments (i.e., three 
molecules of Na+ per molecule of FBP, and two molecules 
K+ and Na+ per molecule of F1P and M6P respectively).
Results from MST parameters (fluorescence, thermo-
phoresis, and temperature jump) measurements were 
exported using the NTA Analysis software (NanoTemper 
Technologies) and normalized (Δ-fluorescence, 
Δ-thermophoresis, Δ-temperature jump) by substracting 
the average of the three values of the lowest F1P, FBP, 
KH2PO4 or NaH2PO4 concentrations (including 0 mM, 
where only the buffer was added) from all measured 
values.
Binding data analysis
To estimate the parameters of FBP-CggR binding reac-
tions we used the quadratic resolution of the law of mass 
action (Eq. 1). We used this equation because the final 
concentration of the labeled protein (0.16 µM for MST 
and 1.0 µM for TSA) is close to the previously reported 
KD for FBP of the high affinity site (Zorrilla, Chaix, et al., 
2007; Řezáčová et al., 2008).
Equation 1:
Here, C0A refers to the concentration of fluorescently 
labeled CggR; C0T refers to the concentration of titrated 
molecule FBP and KD is the dissociation constant, which is 
the parameter we want to estimate. To calculate the frac-
tion bound we normalized Tm and Δ-thermophoresis and 
Δ-temperature jump values with regard to unbound and 
bound stages. Bound and unbound stages were calcu-
lated by averaging the results of two highest and three low-
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Proteins were eluted using modified cytosolic buffer supple-
mented with 235 mM L-histidine. The fractions containing 
the target protein were loaded on a Superdex 200 10/300 
gel filtration column (GE Healthcare), using cytosolic buffer 
as column buffer. After gel filtration the fractions containing 
the proteins were stored at 4°C until use.
Thermal shift assays (TSA)
Samples of 25 µL (final volume) were prepared in ice, and 
contained 5 µL of 5x SYPRO Orange (Molecular Probes; 
Eugene, OR), 1 µL of 1 mg mL-1 of the purified protein 
diluted in cytosolic buffer, and different concentrations of 
the metabolites (FBP, F1P or M6P) in cytosolic buffer. In 
control experiments aimed to test the effect of counter 
ions present in metabolites’ salt solutions, NaCl (for FBP 
and M6P) and KH2PO4 (for F1P) solutions prepared with 
cytosolic buffer were added instead of the corresponding 
metabolite to a final concentrations twice (for F1P and 
M6P) or three times (for FBP) as big as the concentration 
of the metabolite in each corresponding point. Samples 
were transferred into 96 thin-well PCR plates (Bio-Rad), 
the plates sealed with Optical-Quality Sealing Tape (Bio-
Rad), and then analyzed in a CFX96 Real-Time System 
combined with C1000 Touch Thermal Cycler (Bio-Rad). 
Analysis consisted of a single heating cycle from 20°C to 
95°C with increments of 0.5°C steps followed by fluores-
cence intensity monitoring with a charge-coupled device 
camera. The wavelengths for excitation and emission 
were 490 and 575 nm respectively. The Tm was auto-
matically calculated by the control software and corre-
sponded to the local maximum of the first derivative of 
measured fluorescence versus temperature.
Microscale thermophoresis (MST)
Purified CggR and Cra were labeled with Alexa-647 
using the protein labeling NHS RED Kit (NanoTemper 
Technologies, Munich, Germany) as described by the 
manufacturer. The final concentrations of total (12.8 and 
6.6 µM) and labeled (8 µM and 4 µM) CggR and Cra in 
modified cytosolic buffer (Table 2) were determined from 
the absorbance at 280 and 647 nm respectively, using 
a NanoDrop (Thermo Fisher Scientific; Waltham, MA). 
Protein parameters (extinction coefficient at 280 nm and 
molecular weight) were calculated with ProteinParam 
tool (https://web.expasy.org/protparam/) using protein 
sequences retrieved from Uniprot (Cra, P0ACP1; CggR, 
O32253).
Prior to MST measurements, labeled proteins were 
diluted 1:40 in cytosolic buffer containing Tween 20 
(0.05% w/v). Samples were prepared by mixing a volume 
of 5 µL of the diluted labeled protein with 5 µL of a series 
of FBP dilutions (two-fold serial dilution starting at 50 mM), 
for CggR, and F1P or FBP, for Cra, prepared in modified 
cytosolic buffer. The final concentrations of labeled Cra 
and CggR in the assay were 100 and 50 nM respectively. 
For MST measurements, samples were loaded in “pre-
mium coated capillaries” and analyzed in a MST Monolith 
NT.115 (both from NanoTemper Technologies; Munich, 
Germany) at 25°C, using 60% LED power and 40% 
IR-laser power. In control experiments with denatured Cra, 
before sample preparation the protein was denatured with 
7 M of urea and 1 mM DTT, and boiled for 10 minutes. 
In control experiments to assess the influence of counter 
ions in metabolite salt solutions the labeled proteins were 
added to a series of dilutions of KH2PO4 or NaH2PO4 
solutions prepared in cytosolic buffer (corresponding to 
K+ present in F1P and Na+ present in FBP and M6P solu-
tions respectively). The concentration range of each salt 
solution tested in these experiments was adjusted to the 
number of counter ions molecules co-titrated with the cor-
responding metabolite in binding experiments (i.e., three 
molecules of Na+ per molecule of FBP, and two molecules 
K+ and Na+ per molecule of F1P and M6P respectively).
Results from MST parameters (fluorescence, thermo-
phoresis, and temperature jump) measurements were 
exported using the NTA Analysis software (NanoTemper 
Technologies) and normalized (Δ-fluorescence, 
Δ-thermophoresis, Δ-temperature jump) by substracting 
the average of the three values of the lowest F1P, FBP, 
KH2PO4 or NaH2PO4 concentrations (including 0 mM, 
where only the buffer was added) from all measured 
values.
Binding data analysis
To estimate the parameters of FBP-CggR binding reac-
tions we used the quadratic resolution of the law of mass 
action (Eq. 1). We used this equation because the final 
concentration of the labeled protein (0.16 µM for MST 
and 1.0 µM for TSA) is close to the previously reported 
KD for FBP of the high affinity site (Zorrilla, Chaix, et al., 
2007; Řezáčová et al., 2008).
Equation 1:
Here, C0A refers to the concentration of fluorescently 
labeled CggR; C0T refers to the concentration of titrated 
molecule FBP and KD is the dissociation constant, which is 
the parameter we want to estimate. To calculate the frac-
tion bound we normalized Tm and Δ-thermophoresis and 
Δ-temperature jump values with regard to unbound and 
bound stages. Bound and unbound stages were calcu-
lated by averaging the results of two highest and three low-
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point of the titration was normalized by subtracting from 
each value the one calculated for the unbound stage, and 
then this difference was divided by the difference between 
bound and unbound. The KD values were fitted in Matlab 
using maximum likelihood estimation with measurement 
variance determined at each metabolite concentration. 
The interquartile range of the fitted KD was obtained by 
bootstrapping on the measurement errors. The standard 
error of the fit is the standard deviation of the distances 
between the fitted curve and the mean of the data points 
at each ligand concentration.
Electrophoretic mobility shift assays (EMSA)
Fluorescently labeled DNA fragments used in EMSA were 
generated by hybridization of single-stranded forward 
(labeled with Alexa-Fluor-647 at the 5’ end) and reverse 
(unlabeled) oligonucleotides containing the sequence of 
Cra or CggR operator sites or a random DNA sequence 
(Supplementary Table 2). CggR operator sequence 
corresponds to a synthetic CggR-responsive element 
that includes the four conserved nucleotide stretches 
(Zorrilla, Doan, et al., 2007) separated by a randomized 
sequence of the same length as the non-conserved ones 
(Supplementary Note). Oligonucleotides were purchased 
from Integrated DNA Technologies (Coralville, IA), dis-
solved in 100 mM potassium acetate pH 7.5, 30 mM HEPES 
to a final concentration of 100 µM, mixed 1:1, and then incu-
bated for 5 min at 95°C and cooled down at 1°C min-1 to 
room temperature. Hybridization efficiency was assessed 
by electrophoresis in native conditions. In specific, samples 
of the labeled single stranded oligonucleotide and from 
hybridized DNA were analyzed in 10% polyacrylamide gel 
in TBE, run with 0.5X TBE at constant voltage (14 V cm-1) 
at room temperature. After migration, the gel was scanned 
in a Typhoon 9400, using the wavelengths 649 and 665 nm 
for excitation and emission respectively.
Hybridized labeled DNA fragments (final concentration 
40 nM) were incubated 20 min at room temperature with 
1 µM CggR, 0.5 µM Cra or 4 µM BSA, in the presence of 
different concentrations of the metabolites F1P (0.1, 0.2, 
0.5 and 1 mM), FBP (5, 10, 15 and 20 mM) or M6P (5, 
10, 15 and 20 mM) in a final volume of 25 µL in binding 
buffer (Table 2) including 1 µg of salmon sperm DNA. Free 
DNA was resolved from DNA-protein complexes by native 
electrophoresis at 4°C. In control experiments aimed to 
assess solely the influence of Na+ counter ions co-titrated 
along with FBP we added NaCl instead of FBP to a final 
concentration of 3, 15, 30 and 60 mM. In control exper-
iments where the concentration of Na+ was equalized 
across all FBP concentration points, different amounts of 
NaCl were added to the binding reactions to complement 
Na+ co-titrated along with FBP such that every reaction 
contained a total Na+ concentration of 60 mM.
The background-subtracted total intensities of the pro-
tein-DNA complex and the free-DNA bands were deter-
mined, and bound DNA/total DNA was calculated by 
dividing the intensity of the protein-DNA complex band 
by the total DNA (i.e., the sum of the signal from the pro-
tein-DNA complex band plus the one from free-DNA). In 
cases where there are two bands corresponding to free 
DNA we considered both bands for the calculations.
Molecular docking and electrostatic surface potential 
calculation
Docking was performed using the 3BXF structure of 
CggR (Řezáčová et al., 2008). To prepare the structure 
for docking, all water molecules, salt ions and existing 
ligands were removed. Point charges for the docked 
FBP ligand were assigned using AM1- BCC (Jakalian et 
al., 2002). For the docking itself, the standard settings 
of AutodockVina were used (Trott and Olson, 2010). 
The volume of space that the ligand could visit during 
docking was defined as a rectangular box that extended 
at least 10 Å from each side of the protein. As a result, 
the FBP molecule could explore the entire CggR struc-
ture during docking. For a visual search for potential 
FBP binding sites, electrostatic surface potentials were 
calculated by YASARA using a Poisson-Boltzmann sol-
vation model (Baker et al., 2001; Krieger and Vriend, 
2014).
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